BD BACTEC MGIT 960 PZA Kit Recall: False Resistant Test Results Risk
Becton Dickinson recalls BD BACTEC MGIT 960 PZA Kit for potential false resistant results in TB testing. Affected units have specific lot numbers and catalog codes. Contact for remedy.
Lower-risk recall
May intermittently produce falsely resistant results for pyrazinamide (PZA) during susceptibility testing of Mycobacterium tuberculosis isolates.
Contact the company
What happened, in plain English
Becton Dickinson is recalling BD BACTEC MGIT 960 PZA Kits that may give false resistant results for pyrazinamide testing of tuberculosis. This could lead to incorrect treatment decisions if used without correction. Read more at govinfonow.com/recall/54597-bd-bactec-mgit-960-pza-kit-recall-false-resistant-test.
Source Summary by GovInfoNow · govinfonow.com/recall/54597-bd-bactec-mgit-960-pza-kit-recall-false-resistant-test · Updated August 19, 2026 · FDA enforcement record: FDA #Z-2686-2024
Cite this page
“BD BACTEC MGIT 960 PZA Kit Recall: False Resistant Test Results Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/54597-bd-bactec-mgit-960-pza-kit-recall-false-resistant-test. Based on FDA recall #Z-2686-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2686-2024%22&limit=1).
Why it’s dangerous
The kit may intermittently produce false resistant results for pyrazinamide during tuberculosis susceptibility testing. This could lead to incorrect treatment decisions if the false result is not corrected.
Who’s affected
Healthcare professionals using the BD BACTEC MGIT 960 PZA Kit for tuberculosis testing are most at risk. Patients relying on accurate test results could be affected if treatment is mismanaged.
How to tell if you have this one
Check for catalog number 245128 or lot numbers listed in the recall (e.g., 3104416, 3156654). The kit is used for tuberculosis testing in clinical labs.
- Brand
Becton Dickinson- Category
Medical device
What to do — step by step
Check Kit Details
Verify the catalog number (245128) or lot numbers listed in the recall to confirm if your kit is affected.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
FDA distribution: “Worldwide distribution - US Nationwide and the countries of Argentina, Australia, Bangladesh, Belgium, Brunei, Brazil, Canada, China, Costa Rica, Dominican Republic, Guatemala, Guyana, Hong Kong, Haiti, Indonesia, India, Japan, Korea,…” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA published this recall 41 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest medical device recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #Z-2686-2024 (July 18, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2686-2024 to see it in context.
- Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.